1050611-00-1 Usage
Uses
Used in Organic Synthesis:
(3-cyanooxetan-3-yl)acetic acid ethyl ester is used as a building block in organic synthesis for its potential to contribute to the development of pharmaceuticals and agrochemicals. Its unique structure allows for the creation of novel compounds with specific properties and functions.
Used in Pharmaceutical Development:
In the pharmaceutical industry, (3-cyanooxetan-3-yl)acetic acid ethyl ester is used as a key intermediate in the synthesis of new drugs. Its reactivity and the ability to form various derivatives make it valuable for designing and optimizing drug candidates with improved efficacy and safety profiles.
Used in Agrochemical Development:
Similarly, in agrochemicals, (3-cyanooxetan-3-yl)acetic acid ethyl ester serves as a crucial component in the synthesis of new pesticides, herbicides, and other crop protection agents. Its potential to enhance the effectiveness and selectivity of these chemicals is of significant interest to the industry.
Used in Research and Development of New Materials:
(3-cyanooxetan-3-yl)acetic acid ethyl ester is also used in the research and development of new materials, where its unique properties can be leveraged to create innovative materials with specific applications in various industries.
Used in Chemical Process Development:
Furthermore, this compound is utilized in the development of new chemical processes, where its reactivity and properties can be harnessed to improve the efficiency, yield, or selectivity of chemical reactions.
Overall, (3-cyanooxetan-3-yl)acetic acid ethyl ester is a multifaceted chemical with a broad spectrum of applications across different industries, making it a valuable asset in the advancement of science and technology.
Check Digit Verification of cas no
The CAS Registry Mumber 1050611-00-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,0,6,1 and 1 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1050611-00:
(9*1)+(8*0)+(7*5)+(6*0)+(5*6)+(4*1)+(3*1)+(2*0)+(1*0)=81
81 % 10 = 1
So 1050611-00-1 is a valid CAS Registry Number.
1050611-00-1Relevant articles and documents
Macrocyclic MCL-1 inhibitors and methods of use
-
Paragraph 0896, (2019/02/28)
The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).
Oxetanes in drug discovery: Structural and synthetic insights
Wuitschik, Georg,Carreira, Erick M.,Wagner, Bj?rn,Fischer, Holger,Parrilla, Isabelle,Schuler, Franz,Rogers-Evans, Mark,Müller, Klaus
supporting information; experimental part, p. 3227 - 3246 (2010/08/19)
An oxetane can trigger profound changes in aqueous solubility, lipophilicity, metabolic stability, and conformational preference when replacing commonly employed functionalities such as gem-dimethyl or carbonyl groups. The magnitude of these changes depends on the structural context. Thus, by substitution of a gem-dimethyl group with an oxetane, aqueous solubility may increase by a factor of 4 to more than 4000 while reducing the rate of metabolic degradation in most cases. The incorporation of an oxetane into an aliphatic chain can cause conformational changes favoring synclinal rather than antiplanar arrangements of the chain. Additionally spirocyclic oxetanes (e.g., 2-oxa-6-aza-spiro[3.3]heptane) bear remarkable analogies to commonly used fragments in drug discovery, such as morpholine, and are even able to supplant the latter in its solubilizing ability. A rich chemistry of oxetan-3-one and derived Michael acceptors provide venues for the preparation of a broad variety of novel oxetanes not previously documented, thus providing the foundation for their broad use in chemistry and drug discovery.
COMPOUNDS FOR TREATING VIRAL INFECTIONS
-
Page/Page column 87-88, (2008/12/08)
The invention relates to compounds, pharmaceutical compositions and methods useful for treating viral infection.
